Evaluation of transcatheter arterial embolization (TAE) as a therapy for recurrence of heputocelluler carcinoma after hepatic resection.

概要

論文の詳細を見る
We analized nineteen patients suffering from recurrent hepatocellular carcinoma after hepatic resection. They were divided into two groups by postrecurrence therapy, performed with transcatheter arterial embolization (TAE) or not. TAE was performed in twelve patients (TAE group) and the other therapies were performed in seven patients (non-TAE group). On the hepatic resection and recurrence there was no significant difference in the several factors for prognosis between the groups of TAE and non-TAE. Nevertheless, one-and two-year survival rate after recurrence were 91%, 57% in the TAE group, respectively. There was significant difference (p<0.05) in the survival rates between the two groups. In the all patients of TAE group serum AFP values decreased after TAE. In the non-TAE group, there were only two patients decreased with AFP values after therapies.<BR>We concluded that TAE was the more effective therapy for recurrent hepatocellular carcinoma of residual liver after hepatic resection.
社団法人日本肝臓学会の論文